Last Updated: November 16, 2026

Akebia Company Profile

« Back to Dashboard


What is the competitive landscape for AKEBIA

AKEBIA has one approved drug.

There are fourteen US patents protecting AKEBIA drugs.

Summary for Akebia
US Patents:14
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Akebia

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akebia VAFSEO vadadustat TABLET;ORAL 215192-003 Mar 27, 2024 DISCN Yes No 9,701,636 ⤷  Start Trial Y Y ⤷  Start Trial
Akebia VAFSEO vadadustat TABLET;ORAL 215192-001 Mar 27, 2024 RX Yes No 11,324,734 ⤷  Start Trial Y ⤷  Start Trial
Akebia VAFSEO vadadustat TABLET;ORAL 215192-003 Mar 27, 2024 DISCN Yes No 9,987,262 ⤷  Start Trial ⤷  Start Trial
Akebia VAFSEO vadadustat TABLET;ORAL 215192-001 Mar 27, 2024 RX Yes No 9,701,636 ⤷  Start Trial Y Y ⤷  Start Trial
Akebia VAFSEO vadadustat TABLET;ORAL 215192-002 Mar 27, 2024 RX Yes No 7,811,595 ⤷  Start Trial Y Y ⤷  Start Trial
Akebia VAFSEO vadadustat TABLET;ORAL 215192-002 Mar 27, 2024 RX Yes No 11,857,543 ⤷  Start Trial ⤷  Start Trial
Akebia VAFSEO vadadustat TABLET;ORAL 215192-001 Mar 27, 2024 RX Yes No 11,844,756 ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Akebia Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
3007695 C202430024 Spain ⤷  Start Trial PRODUCT NAME: VADADUSTAT; NATIONAL AUTHORISATION NUMBER: EU/1/23/1725; DATE OF AUTHORISATION: 20230424; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/23/1725; DATE OF FIRST AUTHORISATION IN EEA: 20230424
3007695 CR 2024 00026 Denmark ⤷  Start Trial PRODUCT NAME: VADADUSTAT; REG. NO/DATE: EU/1/23/1725 20230425
3007695 PA2024521 Lithuania ⤷  Start Trial PRODUCT NAME: VADADUSTATAS; REGISTRATION NO/DATE: EU/1/23/1725 20230424
3007695 202440023 Slovenia ⤷  Start Trial PRODUCT NAME: VADADUSTAT; NATIONAL AUTHORISATION NUMBER: EU/1/23/1725; DATE OF NATIONAL AUTHORISATION: 20230424; AUTHORITY FOR NATIONAL AUTHORISATION: EU
3007695 122024000039 Germany ⤷  Start Trial PRODUCT NAME: VADADUSTAT (VAFSEO); REGISTRATION NO/DATE: EU/1/23/1725 20230424
3007695 CA 2024 00026 Denmark ⤷  Start Trial PRODUCT NAME: VADADUSTAT; REG. NO/DATE: EU/1/23/1725 20230425
3007695 24/2024 Austria ⤷  Start Trial PRODUCT NAME: VADADUSTAT ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON; REGISTRATION NO/DATE: EU/1/23/1725 (MITTEILUNG) 20230425
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.